Caliway Biopharmaceuticals (TWSE: 6919) today announced the successful End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) for CBL-514, the company's proprietary ...

A new collaborative study from the University of Shizuoka, Kobe University, and Kyoto-based biotech company Noster Inc. has revealed that a natural compound produced by beneficial ...

A new survey of 2,000 Americans by TENA, a leading incontinence brand, highlights the daily struggles of those living with UI – from how it impacts their emotional well-being and daily live to their ...